Newswise — January 13, 2022, NEW YORK – Memorial Sloan Kettering Cancer Center (MSK) today announced that Rémy Evard has joined as its new Chief Digital Officer and Head of Technology. In this role, Evard will be responsible for the overall design and execution of the organization’s digital strategy.
Evard joins MSK from Flagship Pioneering, a venture capital firm that builds first-in-category life sciences companies, where he served as Chief Information and Digital Officer since 2018. Prior to that, Evard was Global Chief Information Officer at the Novartis Institutes of BioMedical Research from 2006 to 2018 and held various technical leadership roles at Argonne National Laboratory from 1996 to 2006, including Chief Information Officer. Evard earned a master’s degree in computer science from the University of Oregon, as well as bachelor’s degrees in computer science and mathematics from Andrews University in Michigan.
“Rémy brings 30 years of technology leadership experience to MSK, and we are thrilled to have him on board,” said Kathryn Martin, Chief Operating Officer at MSK. “He joins MSK at a critical moment in our history as several developments have set the stage for dramatic and far-reaching change in the understanding and treatment of cancer.”
Building on recent investments in digital solutions and technology optimization, Evard will lead the design and execution of the next phase of MSK’s digital strategy, leveraging the power of data, digital innovation, and technology to support scientific excellence and innovative research, exceptional patient care, and education. He will also direct the operations of Digital Informatics & Technology Solutions (DigITs), which includes more than 1,000 employees. He succeeds Claus Jensen, who left MSK in May 2021.
Evard added, “I’m excited to join an institution with such a storied history and be a part of the tremendous impact MSK has on cancer treatment, research, and care. For a technologist, this is an opportunity to help improve the lives of cancer patients and to contribute to humanity’s ongoing quest to conquer cancer at a time when data, analytics, and technology are transforming healthcare, accelerating science, and empowering patients. I look forward to building on the work to accelerate MSK’s digital transformation and help drive continued innovation.”
About Memorial Sloan Kettering Cancer Center (MSK):
As the world’s oldest and largest private cancer center, Memorial Sloan Kettering Cancer Center has devoted more than 135 years to exceptional patient care, influential educational programs, and innovative research to discover more effective strategies to prevent, control and, ultimately, cure cancer. MSK is home to more than 20,000 physicians, scientists, nurses, and staff united by a relentless dedication to conquering cancer. Today, we are one of 51 National Cancer Institute-designated Comprehensive Cancer Centers, with state-of-the-art science and technology supporting groundbreaking clinical studies, personalized treatment, and compassionate care for our patients. We also train the next generation of clinical and scientific leaders in oncology through our continually evolving educational programs, here and around the world. Year after year, we are ranked among the top two cancer hospitals in the country, consistently recognized for our expertise in adult and pediatric oncology specialties. www.mskcc.org.